USANA Health Sciences Inc (USNA)
Net profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 63,788 | 59,817 | 63,399 | 65,264 | 69,350 | 76,875 | 89,276 | 108,353 | 116,505 | 135,814 | 138,990 | 128,733 | 124,664 | 115,789 | 109,505 | 102,906 | 100,526 | 102,103 | 108,921 | 121,450 |
| Revenue (ttm) | US$ in thousands | 923,232 | 929,999 | 950,124 | 976,483 | 1,001,860 | 1,041,382 | 1,082,496 | 1,155,009 | 1,190,168 | 1,235,586 | 1,258,823 | 1,180,028 | 1,137,751 | 1,095,421 | 1,057,506 | 1,054,531 | 1,060,902 | 1,088,627 | 1,124,796 | 1,170,240 |
| Net profit margin | 6.91% | 6.43% | 6.67% | 6.68% | 6.92% | 7.38% | 8.25% | 9.38% | 9.79% | 10.99% | 11.04% | 10.91% | 10.96% | 10.57% | 10.36% | 9.76% | 9.48% | 9.38% | 9.68% | 10.38% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $63,788K ÷ $923,232K
= 6.91%
The net profit margin of USANA Health Sciences Inc has shown some fluctuation over the past five years. The company's net profit margin has been relatively stable, hovering around the range of 6.43% to 11.04%.
In recent quarters, the net profit margin has ranged from 6.43% to 6.91%, indicating that the company has been able to maintain a reasonable level of profitability relative to its revenue.
While the net profit margin has shown some downward trend compared to previous years, with a peak of 11.04% in June 2021, it is still within a healthy range for most of the quarters analyzed.
Overall, USANA Health Sciences Inc appears to have a consistent level of profitability as indicated by its net profit margins, with some quarterly fluctuations typical in the industry. It is important for investors to monitor the trend in net profit margins to assess the company's financial health and performance over time.